Sign in

CIK 0001609809

  • Non-accelerated filer
  • Smaller reporting company

Seres Therapeutics, Inc.

Sign in to watch
Ticker
MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
274326290
Phone
+1 617-945-9626
Business address
200 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
Seres Therapeutics, Inc., Seres Health, Inc.
  1. 4 Open-market sale Shaff Eric D. sold 2,780 shares at $11.02 ($30,636)
  2. 4 Open-market sale DesRosier Thomas sold 3,475 shares at $11.02 ($38,295)
  3. 4 Open-market sale Trucksis Michele sold 2,607 shares at $11.02 ($28,729)
  4. 4 Open-market sale COOK DAVID N sold 1,738 shares at $11.02 ($19,153)
  5. 4/A Open-market sale Aunins John G. sold 1,623 shares at $10.14 ($16,457)
  6. 4 Exercise or conversion President and CEO acquired 40,241 shares (option exercise)
  7. 4 Open-market sale Chief Technology Officer & EVP sold 1,623 shares at $10.14 ($16,457)
  8. 4 Exercise or conversion President and CEO acquired 100,604 shares (option exercise)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 15 of 19 · 380 filings